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Developmental abnormalities in endocardial cushions frequently contribute to congenital heart malformations including septal and
valvular defects. While compelling evidence has been presented to demonstrate that members of the TGF-h superfamily are capable
of inducing endothelial-to-mesenchymal transdifferentiation in the atrioventricular canal, and thus play a key role in formation of
endocardial cushions, the detailed signaling mechanisms of this important developmental process, especially in vivo, are still poorly
known. Several type I receptors (ALKs) for members of the TGF-h superfamily are expressed in the myocardium and endocardium
of the developing heart, including the atrioventricular canal. However, analysis of their functional role during mammalian
development has been significantly complicated by the fact that deletion of the type I receptors in mouse embryos often leads to
early embryonal lethality. Here, we used the Cre/loxP system for endothelial-specific deletion of the type I receptor Alk2 in mouse
embryos. The endothelial-specific Alk2 mutant mice display defects in atrioventricular septa and valves, which result from a failure of
endocardial cells to appropriately transdifferentiate into the mesenchyme in the AV canal. Endocardial cells deficient in Alk2
demonstrate decreased expression of Msx1 and Snail, and reduced phosphorylation of BMP and TGF-h Smads. Moreover, we show
that endocardial cells lacking Alk2 fail to delaminate from AV canal explants. Collectively, these results indicate that the BMP type I
receptor ALK2 in endothelial cells plays a critical non-redundant role in early phases of endocardial cushion formation during cardiac
morphogenesis.
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Cardiovascular malformations are the most common life-
threatening birth defects in humans, affecting approximately
one in one hundred live births (Srivastava, 2001; Hoffman
and Kaplan, 2002). The etiology of these conditions is still
very poorly known, but it often appears to be multi-factorial,
involving both environmental and genetic causes. Among286 (2005) 299 – 310
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very frequent (Schroeder et al., 2003). They arise from a
failure of endocardial cushions to fuse, which leads to a
range of secondary abnormalities, including incomplete
formation of the septum between atria and ventricles and
malformation of the AV valves. AV cushion formation is
initiated by factors that induce endothelial-to-mesenchymal
transdifferentiation (EMT) (Eisenberg and Markwald,
1995), and indeed, it has been shown that the vast majority
of cushion mesenchymal cells are derived from the
endothelium (Kisanuki et al., 2001; Anderson et al., 2003;
de Lange et al., 2004). Subsequent morphogenetic events
lead to elongation, outgrowth and remodeling of cushions to
form mature septa and delicate thin valve leaflets. During
EMT, endothelial cells delaminate from the endocardium
into the underlying acellular hyaluronate-rich substance
called cardiac jelly that separates endocardial and myocar-
dial layers, and transform into cushion mesenchymal cells.
Co-culture experiments have shown that signals from both
the adjacent myocardium and from the extracellular matrix
of the cardiac jelly play a critical role in the endocardial cell
EMT (Eisenberg and Markwald, 1995).
Many soluble growth factors, transmembrane receptors,
intracellular signaling molecules, nuclear factors and gly-
cosaminoglycans are known to induce EMT. Initially, it was
shown that members of the TGF-h superfamily are able to
induce EMT in the chick during cardiac morphogenesis
(Potts and Runyan, 1989; Eisenberg and Markwald, 1995).
The Wnt/h-catenin pathway was shown to be required for
EMT, first in zebrafish (Hurlstone et al., 2003) and
subsequently also in mice (Liebner et al., 2004), while
recent studies suggest that Notch signaling plays a role
upstream of TGF-hs during murine endocardial cushion
transformation (Timmerman et al., 2004). Normal cushion
tissue formation has also been shown to be controlled by
regulators of the Ras signaling pathway (Lakkis and
Epstein, 1998; Camenisch et al., 2002b; Gitler et al.,
2003b). Recently, dynamic temporal and spatial changes
in calcineurin signaling and NFATc1/VEGF expression were
demonstrated to play key roles in endocardial EMT and in
valve development (Chang et al., 2004). However, detailed
signaling mechanisms as well as crosstalk between different
signaling pathways remain largely unknown.
Several studies using a three-dimensional explant culture
model in conjunction with antisense oligonucleotides and
neutralizing antibodies have shown that TGF-hs, partic-
ularly TGF-h2 and -3, as well as BMPs are essential growth
factors for initiation and regulation of EMT (Potts and
Runyan, 1989; Potts et al., 1991; Runyan et al., 1992;
Markwald et al., 1996; Nakajima et al., 2000). In addition,
studies using neutralizing antibodies in the chick explant
culture model have suggested that the prototypical TGF-h
type I receptor, ChALK5, is not involved in the cushion
EMT, while inhibition of a related type I receptor, ChALK2,
prevents the transdifferentiation (Lai et al., 2000). Sub-
sequently, it was shown that constitutively active ALK2alone is sufficient to stimulate EMT (Desgrosellier et al.,
2005). Mice deficient both in BMP5 and BMP7 display
defective cushion development (Solloway and Robertson,
1999), and it was recently reported that a tissue-specific
deletion of the BMP type I receptor Alk3 in myocardial cells
leads to hypoplastic endocardial cushions and decreased
Tgf-b2 expression (Gaussin et al., 2002). In fact, mice
deficient in SMAD6, an inhibitory intracellular signal
mediator of TGF-hs, display endocardial cushion hyper-
plasia (Galvin et al., 2000). However, single TGF-h null
mutants do not demonstrate impaired endocardial EMT
(Shull et al., 1992; Kulkarni et al., 1993; Kaartinen et al.,
1995; Proetzel et al., 1995; Sanford et al., 1997), while mice
deficient in TGF-h2 display defects in later stages of valve
remodeling (Sanford et al., 1997; Bartram et al., 2001).
TGF-h superfamily members signal via heteromeric
receptor complexes composed of two type II and two type
I receptors. Different receptor complexes have been shown
to bind TGF-h ligands with different affinities, which
determine downstream signaling responses (Derynck and
Feng, 1997). For instance, TGF-hs typically bind to a
receptor complex composed of the TGF-h type II receptor
and ALK5, while BMPs regularly signal via BMP type II
receptor and ALK3 (Massague and Chen, 2000). The type I
receptor ALK2 has been shown to display a more restricted
signaling specificity for BMPs 5, -6 and -7 (Macias-Silva et
al., 1998). However, it has been suggested that ALK2 might
mediate TGF-h signals in specific cell types in vitro, such as
mouse mammary epithelial cells (Miettinen et al., 1994).
Studies to unravel the in vivo roles of several BMP
ligands and their receptors in mammals have often been
hampered by the fact that mice deficient in Bmps 2 or -4, as
well as mice deficient in type 1 receptors (Alk2 and Alk3)
die at or immediately after gastrulation, before cardiac
morphogenesis (Winnier et al., 1995; Mishina et al., 1995;
Zhang and Bradley, 1996; Gu et al., 1999; Mishina et al.,
1999). To define the role of Alk2 in endocardial cell
transformation in vivo, we used the Tie2-Cre transgenic
mouse line to target Cre recombinase into endothelial cells
(Kisanuki et al., 2001; Koni et al., 2001). Tie2-Cre
transgenic mice heterozygous for the Alk2 knockout allele
were subsequently crossed with homozygous Alk2Fx/Fx mice
(Kaartinen and Nagy, 2001; Kaartinen et al., 2004; Dudas et
al., 2004). The resulting Alk2/Tie2-Cre mutants display AV
and ventricular septal defects, and show that ALK2 is
required for successful endothelial cell to mesenchyme
transdifferentiation in AV cushions.Materials and methods
Mice and genotyping
Mice homozygous for the Alk2FX allele and mice
heterozygous for the Alk2KO allele were generated and
genotyped as described previously (Kaartinen and Nagy,
J. Wang et al. / Developmental Biology 286 (2005) 299–310 3012001; Kaartinen et al., 2004; Dudas et al., 2004). Tie2-Cre
and Rosa26R Cre (R26R) reporter mice were obtained from
the Jackson Labs and genotyped by PCR (for detailed
protocols see: http://www.jax.org). All mice were main-
tained on mixed genetic backgrounds. All studies were
carried out at the Animal Care Facility of the Saban
Research Institute of Childrens Hospital Los Angeles in
accordance with institutional guidelines.
Histological analyses
Embryonic tissues were fixed with 4% buffered form-
aldehyde for 2–12 h, dehydrated and embedded in paraffin.
Sections (5 Am) were stained with hematoxylin and eosin.
For cryostat sectioning, tissues were fixed in 4% buffered
formaldehyde and equilibrated in 30% sucrose prior to
freezing in HistoPrep (Fisher). Frozen sections were cut at 8
Am. Embryos or sections were stained for h-galactosidase
activity as described (Hogan et al., 1994). Briefly, the
specimens were fixed in 4% buffered formaldehyde for 30
min at room temperature, washed 3 times for 10 min in the
detergent wash and developed for 2 to 6 h in the X-gal
staining solution.
Expression studies
Wholemount and section in situ hybridization on
embryos was carried out as described (Hogan et al., 1994;
Moorman et al., 2001). Probes specific for Msx1 (Furuta et
al., 1997), Snail (Cano et al., 2000), Hey2 (Donovan et al.,
2002), Pdgfra (Gitler et al., 2003a) and Tgf-b2 (Blavier et
al., 2001) were used. To analyze phosphorylation of Smads,
de-paraffinized sections were boiled for 10 min in 10 mM
citrate buffer, pH 6.0 in a pressure cooker and immunos-
tained using antibodies specific for phospho-Smad-1/5/8 or
phopho-Smad-2 (Cell signaling). For immunohistochemis-
try, frozen sections were stained with monoclonal antibodies
to CD31 (Sigma) or to NFATc1 (Developmental Studies
Hybridoma Bank at the University of Iowa) according to
standard procedures and counterstained with DAPI (Harlow
and Lane, 1988).
Apoptosis and cell proliferation
Apoptotic cells were detected using the DeadEnd Fluoro-
metric TUNEL system (Promega). Cell proliferation was
analyzed using the BrdU incorporation assay (Zymed) or by
immunostaining for phosphohistone H3 (Cell signaling).
Explant cultures
Collagen gels (1 mg/ml, type I rat tail collagen from BD)
were prepared in OptiMEM supplemented with 1% fetal calf
serum, 1 ITS (insulin, transferrin and selenium) and
penicillin/streptomysin (1) all from Invitrogen (Sugi et al.,
2004). AV regions of the hearts were dissected from E10embryos, cut longitudally to expose the lumen and placed
on the collagen gels. Additional media were added to the
cultures 2 h later and incubation was continued under
standard tissue culture conditions (37-C, 100% humidity,
8% CO2). For some cultures, TGF-h3 (10 ng/ml, Sigma) or
BMP2 (50 ng/ml, Sigma) was added to the culture media.Results
Alk2 is expressed in endothelial cells in the mouse AV canal
It has previously been shown that the Alk1 gene
(encoding the TGF-h/BMP type I receptor) is expressed in
endothelial cells and that ALK1 mediates TGF-h signaling
in concert with the prototypical TGF-h type I receptor ALK5
during the proliferative phase of angiogenesis (Goumans et
al., 2003). Moreover, it has been suggested that in chick the
type I receptor ALK2, which is closely related to ALK1, is
involved in formation of AV-cushions during cardiac
development by functioning in endothelial-to-mesenchymal
transformation (Lai et al., 2000; Desgrosellier et al., 2005).
Therefore, we were interested in whether ALK2 would also
be involved in endothelial development in mammals,
particularly during cardiac morphogenesis. As a first step,
we analyzed expression of Alk2 in the AV-canal at
embryonic day 10 (E10), when the cushions are forming
(Fig. 1A). Alk2 mRNAwas detected in endocardial cells, as
well as in some underlying mesenchymal cells, as previously
described by Gu et al. (1999). To analyze the function of
Alk2 in mammalian endothelial cells of the AV canal, we
used the tissue-specific Cre/loxP gene targeting strategy. It
has previously been shown that the Tie2 promoter/enhancer
will efficiently target transgene expression to the endothe-
lium, and that mice expressing Cre recombinase under the
control of the Tie2 promoter can be used to abrogate a gene
of interest efficiently and specifically in the endothelium
(Kisanuki et al., 2001; Koni et al., 2001). To verify that this is
indeed the case in the transgenic line that we opted to use
(Koni et al., 2001), we followed the fate of cells recombined
by the Tie2-Cre transgene by using the ROSA26 Cre reporter
(R26R) assay as previously reported (Soriano, 1999; Chai et
al., 2000; Jiang et al., 2000). The double transgenic embryos
(Tie2-Cre+/;R26R+/) were harvested at E12, and stained
for h-galactosidase activity. Positive staining was seen
specifically in endothelial cells (Fig. 1B) and in mesenchy-
mal cells derived from the endocardium, e.g., in the
mesenchyme of endocardial cushions (Fig. 1C) confirming
that this Tie2-Cre transgenic line could efficiently be used to
induce recombination in the endothelial cell lineage. There-
fore, we crossed the Tie2-Cre mice that also were hetero-
zygous for the Alk2 knockout allele with mice homozygous
for the floxed Alk2 (Alk2FX/FX) allele (Kaartinen and Nagy,
2001; Kaartinen et al., 2004; Dudas et al., 2004). Efficiency
of the Cre-induced recombination in the AV canal at E10 was
verified by using the RT-PCR strategy as previously
Table 1
Genotype distribution of embryos from Alk2KO;Tie2-Cre+/  Alk2FX/FX
crosses
Genotype E10–E11
(n = 307)
E14–E15
(n = 97)
Alk2KO/Tie2-Cre+ 89 (22.5%) 11 (10.2%)
Alk2WT/Tie2-Cre+ 108 (27.3%) 28 (28.8%)
Alk2KO/Tie2-Cre
and Alk2WT/Tie2-Cre
199 (50.2%) 58 (59.8%)
Fig. 1. Targeted deletion of Alk2 in the endothelium. (A) Alk2 is expressed in endocardial cushions at E10 (arrow points to the positive in situ hybridization
signal [blue] in endothelial cells). (B–C) The Tie2-Cre transgene specifically induces recombination in endothelial cells (B) and in cells derived from them, i.e.,
in the mesenchyme of endocardial cushions (arrows in panel C) as demonstrated using R26R reporter assay and staining for h-galactosidase activity (Blue
stain), counter stained with eosin. (D) The RT-PCR analysis of mRNA isolated from the AV-canal tissues at E10.0 in wild-type (WT = Tie2-Cre+/;Alk2WT/WT),
heterozygote (He = Tie2-Cre+/;Alk2KO/WT) and homozygote (Ho = Tie2-Cre+/;Alk2FX/KO) mutant embryos. Shorter amplification product (284 bp) was
detected in heterozygote and homozygote embryos, confirming a successful recombination event in targeted tissues resulting in a truncated allele. (E–H)
Wholemount staining of control (Tie2-Cre+/;Alk2FX/WT;R26R+/) and Alk2/Tie2-Cre mutant (Tie2-Cre+/;Alk2FX/KO;R26R+/) embryos for b-galactosidase
activity (blue color); R26R lineage tracing assay. Comparable reporter activity can be seen in mutants (F, H) and controls (E, G), including the AV canal
(arrows, G and H). Numbers (3, 4, 6) in panels G and H depict the aortic arch arteries. (I –L) Endocardial cushions (arrowheads in panels I–L) form in
Alk2/Tie2-Cre mutants (J, L), but appear considerably smaller than in controls at E10.5 (I, K). (M) Quantification of mesenchymal cells in AV cushions at
E10.5; mean T SD; *P < 0.01 (n = 8, total number of mesenchymal cells were counted per parasagittal section; 3 sections analyzed per sample). A, Atrium; V,
ventricle. Magnification: A, 20; B, 5; C, 10; D–F, 3; G–H, 7; I–J, 10; K–L, 40.
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Alk2 gene was effectively recombined by the Tie2-Cre
transgene (Fig. 1D). To compare the overall vascular
phenotype between controls and Alk2/Tie2-Cre mutants
early in development, we crossed Alk2KO/WT;Tie2-Cre males
with females that were homozygous both for the AlkFX and
R26R alleles (Alk2FX/FX;R26R+/+), harvested embryos at
E9.5 and stained them for b-galactosidase activity (Figs.
1E–H). Blood vessels were strongly stained both in controls
and mutants demonstrating that vascular development was
not significantly affected by the loss of Alk2 activity in
endothelial cells.
Alk2/Tie2-Cre mutants display AV-canal defects
Genotype analysis of embryos from Alk2KO/WT/Tie2-
Cre+/  Alk2FX/FX crosses at E14.5 revealed that only10% instead of the expected 25% of Alk2/Tie2-Cre mutants
could be recovered at that time point (Table 1). In
histological sections at E10, the endocardial cushions
appeared smaller in mutants than in controls (Figs. 1I–L).
A dramatic reduction in mesenchymal cell number was
particularly evident in the superior cushion and differed
significantly from that of controls (P < 0.01) (Fig. 1M).
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showed a range of cardiac defects (Fig. 2). Most of them (15
out of 17 studied) had a ventricular septal defect, of varying
severity, where the secondary ventricular foramen has not
closed. In addition, 11 had defective AV septation and valve
development. The AV cushions were of variable size, shape
and degree of fusion with one another, or with other septal
structures. For example, the primary atrial foramen was still
patent, allowing blood to shunt between right and left atria
in 5 embryos. Outgrowth and formation of AV leaflets were
also variable. In some, cushion tissue was sparse or absent
altogether from most of the AV junction, especially on the
right, although prominent trabecular structures, perhaps
those that would normally support the developing leaflet
cushions, were still evident. In contrast, outflow tract (OFT)
septation and OFT leaflet formation appeared normal (Fig. 2
and data not shown).
Alk2 is not required in cardiac myocytes during heart
organogenesis
Although our expression studies suggest that Alk2 is
not strongly expressed in the myocardium, we could not
exclude the possibility that low level Alk2 expression
would still play a critical role in this cell type. Therefore,
we deleted Alk2 in the myocardium by using the cardiacFig. 2. Tissue-specific abrogation of Alk2 in endothelial cells leads to septal and va
in a control (A–C) and mutant (D–F) at E14.5. Defects can be seen both in ventric
well as in AV valves (arrowhead in panel F). In contrast, tissue-specific abrogation
E14. Sections on comparable levels are shown. Magnification: 5.myocyte-specific Cre mouse line (aMHC-Cre) as pre-
viously described (Gaussin et al., 2002). Alk2/aMHC-Cre
mice are viable and failed to display any detectable
altered cardiac phenotype (Fig. 2) demonstrating, that
unlike Alk3 (Gaussin et al., 2002), expression of Alk2 in
cardiac myocytes is not required during this developmen-
tal stage.
Endothelial cells deficient in Alk2 fail to populate the
mesenchyme of the AV cushions in vivo
To follow the fate of Alk2-deficient endothelial cells
during AV canal development, we applied the R26R reporter
assay described above. Analysis of parasagittal sections of
control embryos (at E10–E12) revealed that both the
endocardium as well as the underlying mesenchyme of AV
cushions stained positive for the h-galactosidase activity
(Figs. 3A, E, G). In contrast, the mesenchyme of mutant AV
cushions displayed only a few positively staining cells, while
AV canal endocardial cells deficient in Alk2 demonstrated
strong positive h-galactosidase staining (Figs. 3B, F, H).
Comparison of the cardiac phenotype between Alk2/Tie2-Cre
and Alk2/Tie2-Cre;R26R mutants did not reveal any histo-
logical differences between these two backgrounds (data not
shown). Consistent with the histological studies (Fig. 2), the
cushions of Alk2 mutants were overall smaller and lesslvular defects. Transverse sections on 3 different levels from rostral to caudal
ular (arrow in panel E) and atrioventricular (arrows in panel F) septation, as
of Alk2 in cardiac myocytes does not impair cardiac development (G–I) at
Fig. 3. Fate mapping of endothelial cells in Alk2/Tie2-Cre mutants. While
endothelial cells covering endocardial AV-cushions stain positive both in
controls (A, E, G) and Alk2/Tie2-Cre mutants (B, F, H) in the R26R reporter
assay, only the wild-type mesenchyme demonstrates a large number of
positively staining cells (parasagittal sections; arrowheads in panel B point
to a few positively staining cells seen in the mesenchyme of Alk2 mutants).
In controls, the proximal outflow tract mesenchyme displayed a large
number of positively staining cells at E11 (arrow in panel C), while in
mutants, no positively staining cells could be seen (arrow in panel D) (C–
D, transverse sections). In older mutant embryos, the AV canal mesen-
chyme displayed a larger number of cells, but still only a few of them
stained positive in the lineage tracing assay (F and H), while about 90% of
the mutant mesenchyme demonstrated positive reporter activity (E and G).
(A–D) Samples (A–B, E10; C–D, E11) were harvested and stained as
wholemounts and sectioned after post-fixation. (E–H) Samples (E–F, E11;
G–H; E12) were cryostat sectioned, and subsequently frozen sections were
stained for h-galactosidase activity. SC, superior endocardial cushion; IC,
inferior endocardial cushion. A, atrium; V, ventricle. Magnification: A–B:
40; E–F: 20; C–D, G–H: 10.
Fig. 4. Endothelial cells deficient in ALK2 fail to populate the valvular and
septal mesenchyme. In controls (A–C), both the membraneous portion of
the interventricular septum and the valve mesenchyme are composed of
cells derived from the endothelium (blue, denoted with white asterisks),
while Alk2/Tie2-Cre mutants (D– I) do not demonstrate similar mesen-
chymal staining in corresponding locations (black asterisks). Arrows in
panels D and G point to the ventricular septal defect. Arrowhead in panel F
points to the abnormal epithelial thickening in a mutant. VS, ventricular
septum; RV, right ventricle; LV, left ventricle. Magnification: A, D–G:
10; B–C, E– I: 20.
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canal cushions, we also examined the contribution of the
endocardially derived cells in the OFT mesenchyme. While
mesenchymal cells of the proximal outflow tract from control
embryos stained strongly positive for h-galactosidase at
E11.0 (Fig. 3C) as previously reported (Kisanuki et al.,
2001), no corresponding positively staining cells could be
seen in the mesenchyme of Alk2/Tie2-Cre mutants (Fig. 3D).
At E14, the mesenchyme of both the AV septum and AV
valves was populated by positively staining cells derived
from the endothelium in controls (Fig. 4). In contrast, the
corresponding mesenchymal structures in Alk2 mutants
showed only a few positively staining cells. In addition,
many mutants showed abnormal endocardial thickenings
(Fig. 4F). Consistent with the histological analyses,Alk2/Tie2-Cre mutants displayed ventricular septal defects
(Fig. 4).
Altered gene expression and Smad activation in the AV
canal of Alk2/Tie2-Cre mutants
The homeodomain protein Msx1 is a well-known
effector of BMP signaling (Suzuki et al., 1997), and its
expression has been shown to be induced by BMPs (Bei and
Maas, 1998). Moreover, it has been demonstrated that the
Msx1 gene is expressed in AV canal endocardial cells during
EMT (Gitler et al., 2003a). Therefore, we investigated
whether abrogation of Alk2 in endothelial cells could
influence Msx1 expression. First, we isolated total RNA
from the AV canal tissues harvested at E10 and analyzed
them by RT-PCR.Msx1 expression was clearly attenuated in
Alk2/Tie2-Cre mutants when compared to controls (Fig.
5AA). Next, we compared the localization of Msx1 mRNA
by section in situ hybridization. In controls, Msx1 was
strongly expressed in endocardial cells in the AV canal as
well as in the cushion mesenchyme at E10 (Fig. 5A). In
contrast, in Alk2/Tie2-Cre mutants, the endothelium of the
superior AV cushion did not display any detectable staining,
and there were only a few positively staining cells in the AV-
cushion mesenchyme (Fig. 5B). Similarly, a transcriptional
repressor Snail has been shown to play a key role in EMT
(Savagner et al., 1997; Batlle et al., 2000; Cano et al., 2000;
Timmerman et al., 2004). In the control AV-canal, the
pattern of Snail expression was very similar to that of Msx1:
Fig. 5.Msx1 and Snail are differentially expressed in Alk2/Tie2-Cre mutants. (AA) Semi-quantitative RT-PCR analysis ofMsx1 and Snail expression in the AV
canal at E10; C, control, M1 and M2, two different mutant samples. h-actin was used as a quality and loading control (b-Act). Msx1 is strongly expressed both
in the endothelium (arrow) and in the underlying mesenchyme in controls (A). In Alk2/Tie2-Cre mutants (B), the AV canal endothelium shows no positive
signal (arrow). Only a few positively staining cells can be seen in the mesenchyme (arrowhead). In controls, the transcriptional repressor Snail is expressed in
both the AV canal endothelium (arrow), mesenchyme and in the atrial endothelium (arrowhead in panel C). Similar to controls, Snail is expressed in the mutant
atrial endocardium (arrowheads in panel D), while the expression in the AV canal endothelium is notably reduced (arrow in panel D). Insets in panels A–D
show the high magnification images (63); red arrows depict the endocardial cells. Endocardial expression of Hey2 (E–F) and Pdgfra (G–H) is comparable
between controls (E, G) and mutants (F, H). Both control (I, K) and Alk2/Tie2-Cre mutant (J, L) samples display similar expression patterns of endothelial cell-
specific proteins, CD31 and NFATc1. Parasagittal sections of either E10 hearts (A–D and G–K) or E11 hearts (E–F). A, atrium; V, ventricle. A–H, section in
situ hybridization; I–L, immunohistochemistry. Magnification: 20.
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the underlying mesenchyme (Fig. 5C). Moreover, Snail
mRNA was detected in atrial endocardial cells, but not in
those of the ventricles. Similar to controls, in Alk2/Tie2-Cre
mutants, Snail was expressed in the atrial, but not in the
ventricular endocardium. However, in the AV canal endo-
thelium, expression of Snail was notably reduced when
compared to controls or to the level of atrial expression in
the same section (Fig. 5D). Recent studies have indicatedthat Notch signaling promotes endocardial cell transforma-
tion (Timmerman et al., 2004). Because a basic helix–
loop–helix transcription factor Hey2 is an important
mediator of Notch signaling (Donovan et al., 2002; Sakata
et al., 2002), we compared the Hey2 expression in Alk2/
Tie2-Cre mutants and controls. We found that in both
control and mutant samples Hey2 was strongly expressed in
the AV canal endocardium (Figs. 5E, F). In concordance
with the earlier published studies, positive expression was
J. Wang et al. / Developmental Biology 286 (2005) 299–310306also found throughout the ventricular myocardium and the
OFT endothelium (data not shown) (Donovan et al., 2002).
In addition, we analyzed expression of Pdgfra, Msx2, Slug
and ErbB2, all genes with a presumed role in the AV canal
development; none of these genes displayed detectable
differences in expression between controls and Alk2/Tie2-
Cre mutants (Figs. 5G, H and data not shown).
To exclude the possibility that the loss of Alk2 in the AV
canal endocardium would cause a developmental delay in
endocardial cell maturation, which would subsequently
disturb cushion formation, we compared expression of
CD31 (a well established endothelial cell marker) and
NFATc1 (previously shown to be strongly and specifically
expressed in endothelial cells of AV cushions at the time
when the cushion mesenchyme is formed) (Ranger et al.,
1998; de la Pompa et al., 1998), in the AV canal at E10
between controls and mutants. As can be seen in Figs. 5I–L,
the expression of both of these markers was comparable
between the genotypes suggesting that delayed endothelial
maturation of the AV canal was not responsible for the
observed phenotypes.
Endothelial cells deficient in Alk2 fail to transdifferentiate
in vitro
AV endocardial explants from both mouse and chick
embryos have been shown to transdifferentiate in vitro,Fig. 6. Endothelial cells deficient in Alk2 fail to transdifferentiate in vitro. (A–F
collagen gels. Phase contrast images of control (A) and Alk2/Tie2-Cre (B) exp
staining (20); counterstaining with DAPI. Transformed cells invading the colla
significantly reduced in Alk2/Tie2-Cre mutants when compared to controls. (G) Q
(10 ng/ml) or BMP2 (50 ng/ml) stimulated transdifferentiation of endothelial cellswhen placed on three-dimensional collagen gels (Bernanke
and Markwald, 1984; Sugi and Markwald, 1996; Yamamura
et al., 1997). We used this culture system and isolated AV
canal tissues from controls and Alk2/Tie2-Cre mutants at
E10.0. After dissection, explants were placed, endocardium
down, onto collagen gels, and incubated under standard
culture conditions for up to 50 h. The explants attached
tightly on the gel and started to beat. After 24 h in culture, a
large number of cells had migrated into the collagen gel
from control explants (Fig. 6). About 90% of these cells
showed a typical elongated fibroblastoid phenotype, while
less than 10% of cells were of an intermediate rounded
phenotype. These round cells presumably represent a
population that is activated, but does not transdifferentiate,
as seen in explants treated with the g-secretase inhibitor,
DAPT (Timmerman et al., 2004). In contrast, the number of
migrating fibroblastoid cells in Alk2 mutants was reduced to
about 10% of that of controls. Exogenous addition of BMP2
(50 ng/ml) or TGF-h3 (10 ng/ml) could not rescue the
migration defect of Alk2/Tie2-Cre mutants (Fig. 6G).
Activation of BMP and TGF-b Smads is reduced in AV
canal endocardial cells of Alk2/Tie2-Cre mutant mice
To establish how loss of Alk2 affects downstream
signaling, we examined phosphorylation of both BMP and
TGF-h Smads using antibodies that specifically recognize) AV-canal explants were harvested at E10 and cultured for 24 h on 3-D
lants. (C–D) FITC-phalloidin staining (10) and (E–F) FITC-Phalloidin
gen gel are indicated by arrowheads. The number of transformed cells is
uantitative analysis of explants. Treatment of mutant explants with TGF-h3
in control explants, but was not able to rescue the Alk2-mutant phenotype.
Fig. 7. Smad activation is affected in Alk2/Tie2-Cre mutants. Both Smad1/5/8 phosphorylation (A–B) and Smad2 (C–D) phosphorylation are notably reduced
in the AV-canal endocardium of Alk2/Tie2-Cre mutants (*** in panels B and D) at E10 when compared to those of controls (arrowheads in panels A and C). A,
atrium; V, ventricle. Magnification: 20.
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displayed a large number of the nuclei staining positive for
phospho-Smad 1/5/8 both in controls and in mutants, the AV
canal endocardium demonstrated positive staining only in
controls (Figs. 7A–B). Surprisingly, the staining pattern of
phospho-Smad2 was also affected in Alk2 mutants when
compared to controls (Figs. 7C–D). These findings suggest
that loss of Alk2 in AV canal endocardial cells affects
activation not only of BMP Smads, which are directly
phosphorylated by ALK2, but also that of related TGF-h
Smads.Discussion
Formation of endocardial cushions during cardiac
morphogenesis is required for normal septal and valvular
morphogenesis. A critical step in this process is trans-
formation of endocardial cells into invasive mesenchymal
cells (EMT). As outlined above, the key role of TGF-h
superfamily member signaling in induction of EMT is well
established, particularly in chick models. However, sub-
stantial interspecies differences have been detected in cell
signaling between avian and mouse AV canal explants
(Camenisch et al., 2002a), and very little is known about
differential roles of type I receptors in mammalian
endocardial cells. To better elucidate individual functions
of the type I receptors during mouse AV canal morpho-
genesis, we deleted the Alk2 gene specifically in endothe-
lial cells. These Alk2/Tie2-Cre mice demonstrate severe
cardiac defects in structures derived from endocardial
cushions.
Our in vivo lineage tracing experiments demonstrated
that in Alk2/Tie2-Cre mutants endothelial cells fail totransdifferentiate to the mesenchyme. While at E10 the
mutant cushions were noticeably smaller and less cellular
than those of controls, at later time points, mutant cushions
contained a surprising number of mesenchymal cells that
did not stain positive for the h-galactosidase activity in a
lineage tracing assay. This could indicate that, in Alk2/
Tie2-Cre mutants, other cell types, e.g., epicardial cells,
which have been implicated in formation of the endocar-
dial cushion mesenchyme (Gittenberger-de Groot et al.,
1998), can substitute for endothelial cells formation of the
mesenchyme. We also considered the possibility that the
Tie2-Cre transgene is transcriptionally regulated by ALK2-
mediated signaling, since TGF-h superfamily members
have been shown to be able to upregulate Tie2 expression
in cultured endothelial cells (Mandriota and Pepper, 1998).
However, this scenario is unlikely, since the lineage tracing
experiments demonstrated comparable staining intensity at
E9.5 between control and mutant AV-canal endothelial
cells. Conversely, it is possible that there were still some
endothelial cells that failed to express Cre in sufficient
quantities for efficient gene recombination, and that, in
Alk2 mutants, these cells could partially compensate the
phenotype resulting from a total lack of endocardial cell
transformation. This is supported by our findings that at
E10 some isolated endothelial cells (both in controls and
mutants) failed to stain positive for the h-galactosidase
activity in a lineage-tracing assay. Moreover, the resulting
morphologies are consistent with a depletion of size and
cell number in the AV cushions. The mutant embryos
recovered at E14.5 might have survived because incom-
plete removal of the Alk2 gene allowed some endocardial
cells to undergo EMT: the resulting structures, although
dysmorphic, would be otherwise normal and hence able to
fuse where size and alignment allowed, extend along
Fig. 8. Hypothetical model for induction of EMT by ALK2-mediated
signaling. BMP binds to a type II receptor, which recruits ALK2. ALK2
becomes phosphorylated, which leads to subsequent phosphorylation of
BMP Smads (1/5/8). Expression of genes encoding the putative down-
stream effectors, Msx1 and Snail, is induced, and endothelial cells become
competent to respond to TGF-hs. This in turn leads to activation of TGF-h
Smads, which is prerequisite for EMT.
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dium, all features observed among the surviving Alk2/Tie2-
Cre embryos.
Previous studies have shown that mesenchymal cells in
the proximal or conal OFT cushions are derived from the
endothelium (Kisanuki et al., 2001), and that proximal OFT
septation is mediated via the BMP type II receptor (Delot et
al., 2003). Therefore, we were interested in determining
whether ALK2 would also be involved in this process.
While our analysis demonstrated that ALK2 function
indeed is necessary for EMT in the proximal OFT, as well
as in the AVC, it also pointed out that despite the lack of
ALK2-mediated EMT, normal OFT septation or semilunar
valve development can still occur. However, based on these
experiments, we cannot exclude the possibility that
defective EMT in conal cushions together with defective
AV cushions may contribute to the formation of VSDs
observed in Alk2/Tie2-Cre mutants. We have previously
shown that mice lacking Alk2 in neural crest cells display
persistent truncus arteriosus as a result of defective outflow
tract septation (Kaartinen et al., 2004). Moreover, mice
lacking Alk3 in the neural crest display similar, albeit not
identical outflow tract defects (Stottmann et al., 2004),
indicating that these two related type I receptors play
distinct non-redundant functions. As the function of Alk3 in
endothelial cells, if any, is currently unknown, we cannot
determine whether Alk2 and Alk3 also display non-
redundant functions in the endothelium during vascular or
cardiac development.
Although ligands signaling via ALK2 in vivo are
currently unknown, it is likely that they include BMPs,
such as BMP2, -5, -6 and -7 (Macias-Silva et al., 1998). In
the AV canal, a spectrum of BMPs is expressed by the
myocardium, and BMP signaling via ALK3 was recently
shown to upregulate mesenchymal expression of TGF-h2
(Gaussin et al., 2002). Subsequently, it was suggested that
BMP2 plays also a critical role in induction of autocrine
TGF-h pathways in endocardial cells (Sugi et al., 2004).
However, our observations that in Alk2/Tie2-Cre mutants
the defect in EMT cannot be rescued by exogenous addition
of TGF-hs, and that activation of both BMP Smads and
TGF-h Smads is affected in Alk2/Tie2-Cre mutants,
suggests that the role of BMP signaling in the endocardium
is not solely the induction of TGF-h expression. Our current
results are more consistent with a model in which BMP
signaling via ALK2 is required to render endothelial cells
permissive to TGF-h signaling (see a schematic model in
Fig. 8). Alternatively, it can be argued that ALK2 mediates
TGF-h signaling to induce EMT, as suggested by Miettinen
et al. (1994) using a mouse mammary epithelial cell line
model. However, this paradigm has been challenged by
recent studies demonstrating that activation of TGF-h
Smads is absolutely required, both in human and mouse
epithelial cell lines, for TGF-h-induced EMT (Piek et al.,
1999; Valcourt et al., 2005), whereas signaling leading to
activation of BMP Smads (i.e., action mediated via ALK2)alone is neither necessary nor sufficient for EMT induction.
A third possibility is that heteromeric TGF-h receptor
complexes may be formed between different type I and type
II receptors. Indeed, this type of signaling mechanism
involving TGFhRII, ALK5 and ALK1 has been demon-
strated to play an important regulatory role in endothelial
cell proliferation (Goumans et al., 2003).
In summary, the role of TGF-hs and BMPs in endocar-
dial cushion formation has been extensively studied in
chick, using in vitro techniques. In contrast, much less is
known about signaling mechanisms of these growth factors
during mammalian development in vivo. Our present results
demonstrate that signaling via the type-I receptor ALK2 is
required for appropriate activation of BMP Smads and
induction of EMT during formation of mouse endocardiac
cushions in vivo, and for subsequent morphogenetic steps
that lead to development and maturation of AV-valve
leaflets and septa. Our present results suggest that Alk2-
mediated signaling maybe part of a critical pathway
involved in pathogenesis of AV septal and valve malforma-
tions, which are among the most common congenital
cardiac birth defects in humans.Acknowledgments
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